Skip to Main Content

Paper Details

Clinical Activity of Pembrolizumab in a Patient With Metastatic Triple-Negative Breast Cancer Without Tumor Programmed Death-Ligand 1 Expression: A Case Report and Correlative Biomarker Analysis.
JCO Precis Oncol
4
2017
Author NameAffiliation
Ossama TawfikUniversity of Kansas Medical Center
  • 1 - 1

Datasets

Release 1.2